|
RaxarDrug - Raxar The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Grepafloxacin Hydrochloride
Strength -
EQ 400MG BASE
Applicant -
OTSUKA
New Drug Application (NDA) Number -
020695
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
May 14, 1998
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Otsuka Pharmaceutical Co Ltd
Raxar
Raxar Eq 200mg Base Tablet; Oral
Raxar Eq 400mg Base Tablet; Oral Neosporin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic Kytril Eq 0.1mg Base/ml (eq 0.1mg Base/ml) Injectable; Injection Kytril Eq 1mg Base/ml (eq 1mg Base/ml) Injectable; Injection Kytril Eq 3mg Base/ml Injectable; Injection Kytril Eq 4mg Base/4ml (eq 1mg Base /ml) Injectable; Injection Kytril Eq 2mg Base/10ml Solution; Oral Kytril Eq 1mg Base Tablet; Oral Kytril Eq 2mg Base Tablet; Oral NewDrugInformation |